JP2016518418A - ノコギリヤシの抽出物とショウガおよびエキナセアの親油性抽出物との組み合わせ、それらの使用、ならびにそれらを含有する製剤 - Google Patents
ノコギリヤシの抽出物とショウガおよびエキナセアの親油性抽出物との組み合わせ、それらの使用、ならびにそれらを含有する製剤 Download PDFInfo
- Publication number
- JP2016518418A JP2016518418A JP2016513289A JP2016513289A JP2016518418A JP 2016518418 A JP2016518418 A JP 2016518418A JP 2016513289 A JP2016513289 A JP 2016513289A JP 2016513289 A JP2016513289 A JP 2016513289A JP 2016518418 A JP2016518418 A JP 2016518418A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- ginger
- echinacea
- saw palmetto
- lipophilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000284 extract Substances 0.000 title claims abstract description 45
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 239000010018 saw palmetto extract Substances 0.000 title claims abstract description 17
- 244000133098 Echinacea angustifolia Species 0.000 title claims abstract description 16
- 235000006886 Zingiber officinale Nutrition 0.000 title claims abstract description 16
- 235000014134 echinacea Nutrition 0.000 title claims abstract description 16
- 235000008397 ginger Nutrition 0.000 title claims abstract description 16
- 229940063845 saw palmetto extract Drugs 0.000 title claims abstract description 11
- 244000273928 Zingiber officinale Species 0.000 title claims abstract 5
- 238000009472 formulation Methods 0.000 title description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 8
- 240000006661 Serenoa repens Species 0.000 claims description 8
- 235000005318 Serenoa repens Nutrition 0.000 claims description 8
- 208000000450 Pelvic Pain Diseases 0.000 claims description 7
- 239000003921 oil Substances 0.000 claims description 7
- 235000019198 oils Nutrition 0.000 claims description 7
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims description 5
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims description 5
- 201000007094 prostatitis Diseases 0.000 claims description 5
- 206010046543 Urinary incontinence Diseases 0.000 claims description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 4
- 239000001569 carbon dioxide Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 3
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 claims description 2
- 229940094199 black currant oil Drugs 0.000 claims description 2
- 235000008524 evening primrose extract Nutrition 0.000 claims description 2
- 229940089020 evening primrose oil Drugs 0.000 claims description 2
- 239000010475 evening primrose oil Substances 0.000 claims description 2
- 235000021323 fish oil Nutrition 0.000 claims description 2
- 235000004426 flaxseed Nutrition 0.000 claims description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 2
- 229940012843 omega-3 fatty acid Drugs 0.000 claims description 2
- 208000017497 prostate disease Diseases 0.000 claims description 2
- 239000011573 trace mineral Substances 0.000 claims description 2
- 235000013619 trace mineral Nutrition 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 claims 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 1
- 241000234314 Zingiber Species 0.000 description 11
- 239000002775 capsule Substances 0.000 description 7
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 5
- 241000219925 Oenothera Species 0.000 description 5
- 235000004496 Oenothera biennis Nutrition 0.000 description 5
- 229940040371 lecithin 10 mg Drugs 0.000 description 5
- 239000008347 soybean phospholipid Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 229940047035 ascorbic acid 20 mg Drugs 0.000 description 4
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 description 4
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- GTLGHKNKLRZSMO-UHFFFAOYSA-N 4-(3-hydroxybutyl)-2-methoxyphenol Chemical compound COC1=CC(CCC(C)O)=CC=C1O GTLGHKNKLRZSMO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 229940002508 ginger extract Drugs 0.000 description 2
- 235000020708 ginger extract Nutrition 0.000 description 2
- 229940047889 isobutyramide Drugs 0.000 description 2
- 239000001751 lycopene Substances 0.000 description 2
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 2
- 229960004999 lycopene Drugs 0.000 description 2
- 235000012661 lycopene Nutrition 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- -1 palmitoyl ascorbic acid Chemical compound 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 206010069632 Bladder dysfunction Diseases 0.000 description 1
- 102000018208 Cannabinoid Receptor Human genes 0.000 description 1
- 108050007331 Cannabinoid receptor Proteins 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 208000025844 Prostatic disease Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 201000001880 Sexual dysfunction Diseases 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 102000011040 TRPV Cation Channels Human genes 0.000 description 1
- 108010062740 TRPV Cation Channels Proteins 0.000 description 1
- 102000003566 TRPV1 Human genes 0.000 description 1
- 101150016206 Trpv1 gene Proteins 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 208000028938 Urination disease Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940094957 androgens and estrogen Drugs 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000013507 chronic prostatitis Diseases 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000009115 maintenance therapy Methods 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000006014 omega-3 oil Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 208000026455 prostate symptom Diseases 0.000 description 1
- 201000004240 prostatic hypertrophy Diseases 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 231100000872 sexual dysfunction Toxicity 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Marine Sciences & Fisheries (AREA)
Abstract
Description
前立腺肥大は、アンドロゲンとエストロゲンとの間のホルモン割合の変化によって引き起こされる年齢依存生理学的事象であり、多くの場合、炎症状態および骨盤痛に伴う、排尿障害、頻尿および失禁等の一連の不快な事象によって特徴付けられる。
驚くべきことに、ノコギリヤシの抽出物を、ショウガの親油性抽出物およびエキナセアまたはカホクザンショウの親油性抽出物と組み合わせることにより、該抽出物を単独に使用する、個々に投与したときには観察されない、前立腺症における炎症および一般的な骨盤痛の急速な軽減を伴って、完全に退行することを見出した。
ノコギリヤシの抽出物 120mg
ショウガの親油性抽出物 25mg
エキナセアの親油性抽出物 5mg
大豆レシチン 10mg
パルミトイルアスコルビン酸 20mg
メマツヨイグサの親油性抽出物 150mg
例2 油用のセルロースカプセル
ノコギリヤシの抽出物 120mg
ショウガの親油性抽出物 50mg
エキナセアの親油性抽出物 10mg
大豆レシチン 10mg
メマツヨイグサの親油性抽出物 150mg
例3 錠剤
ノコギリヤシの抽出物 120mg
ショウガの親油性抽出物 50mg
エキナセアの親油性抽出物 10mg
大豆レシチン 10mg
パルミトイルアスコルビン酸 20mg
メマツヨイグサの親油性抽出物 150mg。
ノコギリヤシの抽出物 130mg
ショウガの親油性抽出物 25mg
エキナセアの親油性抽出物 5mg
大豆レシチン 10mg
パルミトイルアスコルビン酸 20mg
トマトの抽出物(リコピン10%) 50mg
メマツヨイグサの親油性抽出物 150mg
例5 ソフトゼラチンカプセル
ノコギリヤシの抽出物 120mg
ショウガの親油性抽出物 25mg
カホクザンショウの親油性抽出物 5mg
大豆レシチン 10mg
パルミトイルアスコルビン酸 20mg
メマツヨイグサの親油性抽出物 150mg。
Claims (7)
- ノコギリヤシの抽出物と、ショウガの親油性抽出物と、エキナセアまたはカホクザンショウの親油性抽出物とを含有する組成物。
- 前記ノコギリヤシ、ショウガ、エキナセアおよびカホクザンショウの抽出物が、超臨界二酸化炭素を用いて抽出することにより調製される、請求項1に記載の組成物。
- 前記ノコギリヤシの抽出物:ショウガの親油性抽出物:エキナセアまたはカホクザンショウの親油性抽出物の比が、1:0.25〜0.5:0.05〜01である、請求項1または2に記載の組成物。
- さらに、オメガ3脂肪酸が豊富である油を含有する、請求項1〜3のいずれかに記載の組成物。
- 前記油が、メマツヨイグサ油、アマ油またはクロスグリ油、および天然または半合成の魚油、から選択される、請求項4に記載の組成物。
- さらに、抗酸化剤および微量元素を含有する、請求項1〜5のいずれかに記載の組成物。
- 尿失禁、良性前立腺肥大、前立腺炎および前立腺症、ならびに骨盤痛の治療に使用するための、請求項1〜6のいずれかに記載の組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000807A ITMI20130807A1 (it) | 2013-05-16 | 2013-05-16 | Combinazioni di estratti di serenoa repens e di estratti lipofili di zingiber officinalis e di echinacea angustifolia, loro uso e formulazioni che li contengono |
ITMI2013A000807 | 2013-05-16 | ||
PCT/EP2014/059297 WO2014184063A1 (en) | 2013-05-16 | 2014-05-07 | Combinations of extracts of serenoa repens and lipophilic extracts of zingiber officinalis and echinacea angustifolia, the use thereof, and formulations containing them |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2016518418A true JP2016518418A (ja) | 2016-06-23 |
JP6502924B2 JP6502924B2 (ja) | 2019-04-17 |
Family
ID=48670706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016513289A Expired - Fee Related JP6502924B2 (ja) | 2013-05-16 | 2014-05-07 | ノコギリヤシの抽出物とショウガおよびエキナセアの親油性抽出物との組み合わせ、それらの使用、ならびにそれらを含有する製剤 |
Country Status (22)
Country | Link |
---|---|
US (2) | US9730974B2 (ja) |
EP (2) | EP2996705B1 (ja) |
JP (1) | JP6502924B2 (ja) |
KR (1) | KR102218751B1 (ja) |
CN (2) | CN105431160A (ja) |
AU (1) | AU2014267529B2 (ja) |
BR (1) | BR112015028234A2 (ja) |
CA (1) | CA2912488C (ja) |
DK (1) | DK2996705T3 (ja) |
ES (1) | ES2684579T3 (ja) |
HK (1) | HK1222805A1 (ja) |
HU (1) | HUE040106T2 (ja) |
IL (1) | IL242554B (ja) |
IT (1) | ITMI20130807A1 (ja) |
MX (1) | MX360308B (ja) |
PL (1) | PL2996705T3 (ja) |
PT (1) | PT2996705T (ja) |
RU (1) | RU2659153C2 (ja) |
SG (1) | SG11201509349QA (ja) |
SI (1) | SI2996705T1 (ja) |
TR (1) | TR201816153T4 (ja) |
WO (1) | WO2014184063A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2610208B1 (es) * | 2015-10-22 | 2018-02-07 | Innovativehealth Group, S.L. | Formulación cosmética de uso tópico para el cuidado de la piel atópica |
IT201900007044A1 (it) * | 2019-05-23 | 2020-11-23 | Neilos S R L | Composizione per l’uso nella prevenzione e/o trattamento di patologie associate alla prostata |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6261607B1 (en) * | 1999-10-19 | 2001-07-17 | Thomas Newmark | Composition for promoting prostate health containing selenium and herbal extracts |
JP2007528361A (ja) * | 2003-07-08 | 2007-10-11 | インデナ エッセ ピ ア | 前立腺障害の治療および予防のための生薬組成物 |
WO2008094873A1 (en) * | 2007-01-29 | 2008-08-07 | Ligums John E | Therapeutic bph composition |
JP2011512371A (ja) * | 2008-02-22 | 2011-04-21 | インデナ エッセ ピ ア | 良性前立腺肥大、前立腺炎、前立腺炎様症候群および前立腺癌の治療のための組成物 |
WO2011086007A1 (en) * | 2010-01-12 | 2011-07-21 | Indena S.P.A. | Compositions comprising andrographics paniculata and gingko biloba extracts complexed with phospholipids |
WO2012013551A1 (en) * | 2010-07-26 | 2012-02-02 | Indena S.P.A. | Formulations containing extracts of echinacea angustifolia and zingiber officinale which are useful in reducing inflammation and peripheral pain |
JP2012515715A (ja) * | 2009-01-20 | 2012-07-12 | インデナ エッセ ピ ア | 胃−食道逆流および化学療法誘発嘔吐の予防および治療のための、ショウガおよびエキネシアの親油性抽出物を含む組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1190129B (it) * | 1986-06-17 | 1988-02-10 | Indena Spa | Procedimento di estrazione di frutti oleaginosi |
US6039950A (en) * | 1995-04-14 | 2000-03-21 | University Of Southern California | Pharmaceutical grade saw palmetto |
ITMI981542A1 (it) * | 1998-07-07 | 2000-01-07 | Indena Spa | Estratti di zanthoxylum bungeanum e loro formulazioni farmaceutiche e cosmetiche |
-
2013
- 2013-05-16 IT IT000807A patent/ITMI20130807A1/it unknown
-
2014
- 2014-05-07 HU HUE14726547A patent/HUE040106T2/hu unknown
- 2014-05-07 US US14/890,932 patent/US9730974B2/en active Active
- 2014-05-07 PL PL14726547T patent/PL2996705T3/pl unknown
- 2014-05-07 SG SG11201509349QA patent/SG11201509349QA/en unknown
- 2014-05-07 PT PT14726547T patent/PT2996705T/pt unknown
- 2014-05-07 TR TR2018/16153T patent/TR201816153T4/tr unknown
- 2014-05-07 MX MX2015015773A patent/MX360308B/es active IP Right Grant
- 2014-05-07 AU AU2014267529A patent/AU2014267529B2/en not_active Ceased
- 2014-05-07 RU RU2015148771A patent/RU2659153C2/ru active
- 2014-05-07 EP EP14726547.4A patent/EP2996705B1/en active Active
- 2014-05-07 KR KR1020157032614A patent/KR102218751B1/ko active IP Right Grant
- 2014-05-07 CA CA2912488A patent/CA2912488C/en active Active
- 2014-05-07 JP JP2016513289A patent/JP6502924B2/ja not_active Expired - Fee Related
- 2014-05-07 WO PCT/EP2014/059297 patent/WO2014184063A1/en active Application Filing
- 2014-05-07 CN CN201480027446.1A patent/CN105431160A/zh active Pending
- 2014-05-07 ES ES14726547.4T patent/ES2684579T3/es active Active
- 2014-05-07 DK DK14726547.4T patent/DK2996705T3/en active
- 2014-05-07 BR BR112015028234A patent/BR112015028234A2/pt not_active Application Discontinuation
- 2014-05-07 SI SI201430944T patent/SI2996705T1/sl unknown
- 2014-05-07 CN CN202110401673.8A patent/CN112870329A/zh active Pending
- 2014-05-07 EP EP18171685.3A patent/EP3391894A1/en not_active Withdrawn
-
2015
- 2015-11-12 IL IL242554A patent/IL242554B/en active IP Right Grant
-
2016
- 2016-09-21 HK HK16111079.3A patent/HK1222805A1/zh unknown
-
2017
- 2017-06-19 US US15/626,203 patent/US10016478B2/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6261607B1 (en) * | 1999-10-19 | 2001-07-17 | Thomas Newmark | Composition for promoting prostate health containing selenium and herbal extracts |
JP2007528361A (ja) * | 2003-07-08 | 2007-10-11 | インデナ エッセ ピ ア | 前立腺障害の治療および予防のための生薬組成物 |
WO2008094873A1 (en) * | 2007-01-29 | 2008-08-07 | Ligums John E | Therapeutic bph composition |
JP2011512371A (ja) * | 2008-02-22 | 2011-04-21 | インデナ エッセ ピ ア | 良性前立腺肥大、前立腺炎、前立腺炎様症候群および前立腺癌の治療のための組成物 |
JP2012515715A (ja) * | 2009-01-20 | 2012-07-12 | インデナ エッセ ピ ア | 胃−食道逆流および化学療法誘発嘔吐の予防および治療のための、ショウガおよびエキネシアの親油性抽出物を含む組成物 |
WO2011086007A1 (en) * | 2010-01-12 | 2011-07-21 | Indena S.P.A. | Compositions comprising andrographics paniculata and gingko biloba extracts complexed with phospholipids |
WO2012013551A1 (en) * | 2010-07-26 | 2012-02-02 | Indena S.P.A. | Formulations containing extracts of echinacea angustifolia and zingiber officinale which are useful in reducing inflammation and peripheral pain |
Non-Patent Citations (1)
Title |
---|
GINGER & THE PROSTATE, JPN6018003698, 22 July 2011 (2011-07-22), ISSN: 0003890693 * |
Also Published As
Publication number | Publication date |
---|---|
EP3391894A1 (en) | 2018-10-24 |
MX360308B (es) | 2018-10-26 |
ITMI20130807A1 (it) | 2014-11-17 |
IL242554B (en) | 2019-09-26 |
KR102218751B1 (ko) | 2021-02-23 |
US20170281708A1 (en) | 2017-10-05 |
SI2996705T1 (sl) | 2018-12-31 |
CN112870329A (zh) | 2021-06-01 |
MX2015015773A (es) | 2016-03-15 |
JP6502924B2 (ja) | 2019-04-17 |
PL2996705T3 (pl) | 2019-03-29 |
BR112015028234A2 (pt) | 2017-07-25 |
RU2015148771A (ru) | 2017-05-17 |
HUE040106T2 (hu) | 2019-02-28 |
KR20160008551A (ko) | 2016-01-22 |
HK1222805A1 (zh) | 2017-07-14 |
EP2996705B1 (en) | 2018-08-01 |
ES2684579T3 (es) | 2018-10-03 |
US9730974B2 (en) | 2017-08-15 |
RU2659153C2 (ru) | 2018-06-28 |
TR201816153T4 (tr) | 2018-11-21 |
PT2996705T (pt) | 2018-10-08 |
DK2996705T3 (en) | 2018-09-03 |
WO2014184063A1 (en) | 2014-11-20 |
EP2996705A1 (en) | 2016-03-23 |
US20160113992A1 (en) | 2016-04-28 |
US10016478B2 (en) | 2018-07-10 |
CN105431160A (zh) | 2016-03-23 |
SG11201509349QA (en) | 2015-12-30 |
CA2912488C (en) | 2022-07-12 |
AU2014267529A1 (en) | 2015-12-03 |
CA2912488A1 (en) | 2014-11-20 |
AU2014267529B2 (en) | 2019-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kooti et al. | Therapeutic and pharmacological potential of Foeniculum vulgare Mill: a review | |
JP6502924B2 (ja) | ノコギリヤシの抽出物とショウガおよびエキナセアの親油性抽出物との組み合わせ、それらの使用、ならびにそれらを含有する製剤 | |
Krimer-Malešević et al. | Phenolic acids in pumpkin (Cucurbita pepo L.) seeds | |
Brendler et al. | Devil’s Claw (Harpagophytum procumbens DC) an evidence-based systematic review by the natural standard research collaboration | |
EP1637149A1 (de) | Nahrungsergänzungsmittel für den Mann | |
Cheetham | Role of complimentary therapy for male LUTS | |
AU2020260090B2 (en) | Novel hemp and PEA formulation and its use | |
Negm | Effect of Soybean, Virgin Coconut and Moringa oleifera Seed Oils on the Propylthiouracil Induced Hypothyroidism in Rats | |
EP3111930A2 (de) | Zusammensetzung zur behandlung von depressionen, bipolaren störungen, rezidivierenden depressiven störungen und anderen anhaltenden affektiven störungen | |
CN106072584A (zh) | 一种叶黄素酯和沙棘油复合型食用保健品 | |
Valizadeh et al. | The therapeutic effects of cinnamon on polycystic ovary syndrome: A review | |
Gabal et al. | Possible beneficial effects of Chia (Salvia hispanica L.) and Anise (Pimpinella anisum L.) seeds oils on ulcerative colitis rat model | |
Fatima et al. | Nanophytotherapeutic Potential of Essential Oils Against Candida Infections | |
Rabeh | Effect of halawa tahinia alone or with ginger and cinnamon on sex hormones in adult male rats | |
Raees et al. | Dietary Strategies for Osteoarthritis: An In-depth Look at the Sesame Seed Connection | |
Essa et al. | Flaxseeds for brain health | |
ISTUDOR | Side effects and toxicity of some vegetal products included in nutritional supplements. | |
DE202022107141U1 (de) | Zusammensetzung zur Aktivierung und/oder Stimulierung des limbischen Systems, diese enthaltende Kapsel oder Tablette sowie deren Verwendung als Nahrungsergänzungsmittel oder Arzneimittel | |
DE112012003484T5 (de) | Tribulus terrestris-, Avena sativa- und Panax ginseng-Extraktkombination | |
Howe | Polycystic ovarian syndrome (PCOS) | |
DE202016106397U1 (de) | Mittel zur vorzugsweise krebspräventiven Behandlung bei Menschen | |
Wojcikowski | Summaries of CM Research | |
Roni et al. | Traditional herbal interventions for premenstrual syndrome management: a comprehensive literature review |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20170428 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20180206 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180426 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20181002 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190109 |
|
RD13 | Notification of appointment of power of sub attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7433 Effective date: 20190110 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20190110 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20190214 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20190305 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20190322 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6502924 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |